Oramed granted combination therapy patent for treating diabetes

Oramed Pharmaceuticals announced that the United States Patent and Trademark Office has granted the company a patent titled "Methods and Compositions for Treating Diabetes." The patent serves as an extension to a patent previously granted in May 2022 and addresses methods and compositions for treating diabetes mellitus through oral pharmaceutical compositions comprising insulin in combination with Glucagon-like Peptide 1.